Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
2.610
+0.005 (0.19%)
Nov 13, 2026, 4:00 PM EST - Market closed

Bluejay Diagnostics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----0.25-
Revenue Growth
------
Gross Profit
----0.05-
Operating Income
-7.77-6.92-7.17-10.31-9.32-3.23
Net Income
-7.68-6.85-20.94-9.95-9.3-3.49
Earnings Per Share
-14.18-61.01-1826.98---
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
7.385.164.32.2110.1119.05
Total Debt
0.050.130.240.370.51-
Net Cash (Debt)
7.335.044.071.849.619.05
Net Cash Growth
150.28%23.83%121.19%-80.85%-49.59%-
Net Cash Per Share
13.5344.85354.77---

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-6.55-6.05-7.82-8.31-7.74-4.37
Capital Expenditures
-0.53-0.17-0.31-0.7-1.2-0.02
Free Cash Flow
-7.08-6.23-8.13-9.02-8.94-4.39
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----19.64%-
Operating Margin
-----3741.48%-
Pretax Margin
-----3733.11%-
Profit Margin
-----3733.11%-
FCF Margin
-----3590.13%-

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----30.66-